Innovator IBD Breakout Opportunities ETF (BOUT)

Assets	$11.75M
Expense Ratio	0.85%
PE Ratio	33.62
Shares Out	300,000
Dividend (ttm)	$0.23
Dividend Yield	0.57%
Ex-Dividend Date	Dec 31, 2024
Payout Frequency	n/a
Payout Ratio	19.63%

Volume	968
Open	39.10
Previous Close	38.97
Day's Range	39.10 - 39.66
52-Week Low	31.08
52-Week High	42.41
Beta	1.09
Holdings	52
Inception Date	Sep 13, 2018

About BOUT

Fund Home Page

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is issued by Innovator.

• Asset Class: Equity
• Category: Mid-Cap Growth
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BOUT
• ETF Provider: Innovator
• Index Tracked: IBD Breakout Stocks Total Return

Top 10 Holdings

34.72% of assets

Name	Symbol	Weight
Flotek Industries, Inc.	FTK	3.73%
Madrigal Pharmaceuticals, Inc.	MDGL	3.57%
EQT Corporation	EQT	3.56%
MasTec, Inc.	MTZ	3.56%
CrowdStrike Holdings, Inc.	CRWD	3.50%
MYR Group Inc.	MYRG	3.45%
Eastern Bankshares, Inc.	EBC	3.42%
Cboe Global Markets, Inc.	CBOE	3.38%
Kratos Defense & Security Solutions, Inc.	KTOS	3.28%
Warby Parker Inc.	WRBY	3.26%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 31, 2024	$0.22753	Jan 2, 2025
Jul 31, 2024	$0.0059	Aug 1, 2024
Dec 28, 2023	$0.43704	Jan 2, 2024
Dec 29, 2022	$0.39823	Jan 3, 2023
Dec 27, 2018	$0.0389	Jan 2, 2019

Performance

BOUT had a total return of 9.98% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.24%.